|
|
 |
|
Total Number of Holdings (excluding cash): 51
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$46,455.00 |
2.44% |
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$44,547.90 |
2.34% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$44,507.15 |
2.33% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$42,519.41 |
2.23% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$41,422.50 |
2.17% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$41,178.52 |
2.16% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$40,990.56 |
2.15% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$40,374.40 |
2.12% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$40,300.26 |
2.11% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$40,064.18 |
2.10% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$39,804.21 |
2.09% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$39,461.40 |
2.07% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$39,233.24 |
2.06% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$38,835.96 |
2.04% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$38,961.00 |
2.04% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$38,712.50 |
2.03% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$38,764.65 |
2.03% |
| Steris Plc |
STE |
G8473T100 |
173 |
$38,668.96 |
2.03% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,601.36 |
2.02% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$38,453.91 |
2.02% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$38,330.70 |
2.01% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$38,270.16 |
2.01% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$38,047.30 |
2.00% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$37,919.74 |
1.99% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$37,728.98 |
1.98% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$37,808.10 |
1.98% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$37,673.16 |
1.98% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$37,617.74 |
1.97% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$37,546.95 |
1.97% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$37,474.50 |
1.97% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$37,580.10 |
1.97% |
| Waters Corporation |
WAT |
941848103 |
121 |
$37,655.20 |
1.97% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$37,314.04 |
1.96% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$37,097.19 |
1.95% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$37,035.18 |
1.94% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$36,832.03 |
1.93% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$36,784.21 |
1.93% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$36,666.44 |
1.92% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$36,615.28 |
1.92% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$36,675.63 |
1.92% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$36,339.64 |
1.91% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$36,402.60 |
1.91% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$36,249.71 |
1.90% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$35,795.89 |
1.88% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$35,604.80 |
1.87% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$35,615.85 |
1.87% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$35,202.90 |
1.85% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$34,615.09 |
1.82% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$31,246.70 |
1.64% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$21,482.47 |
1.13% |
| US Dollar |
$USD |
|
7,539 |
$7,538.75 |
0.40% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|